IMI
The firm is also developing an instrument-free molecular diagnostic assay technology for the home testing market.
IMI Chooses Five Diagnostic Projects as Part of €72M European COVID-19 Initiative
The IMI announced the call in February with an initial budget of €45 million but raised the total funding amount to €72 million.
IMI Issues €45M Call for New SARS-CoV-2 Diagnostics, Therapeutics
The organization is looking to fund new tests for rapid detection, stratification, and monitoring of patients.
VALUE-Dx involves six IVD companies and is being heralded by participants as an opportunity for competitors to work together to improve test adoption.